Glomus tumor Radiotherapy

Radiotherapy (also known as radiotherapy) is used for glomus tumors in the various stages of the disease in order to achieve a cure for the disease (curative radiotherapy), either alone or in combination with surgery.

Procedure

Radiation therapy focuses high-energy X-rays on the tumor inside the body to specifically kill it. Radiotherapy is either an equivalent alternative to surgery in the treatment of glomus tumors or is used when surgery is not possible.

In the case of glomus tumors, surgical removal of the tumor is the treatment of first choice for fit patients. In older patients, with poor lung function, in the presence of underlying diseases, e.g. heart disease, which make anesthesia risky, or if surgery is not desired, so-called body stereotactic radiation therapy (SBRT) is an alternative treatment.

SBRT is a highly focused radiation treatment, with an accuracy in the millimeter range, and can kill the glomus tumor and achieve a cure in the vast majority of patients. Typically, 5 outpatient radiotherapy sessions are carried out over 30 minutes. Depending on the extent of the tumor, radiotherapy may also be necessary as fractionated treatment over several weeks. Close and personal support is a matter of course for us.

Body stereotactic radiotherapy (SBRT) is a clinical and scientific focus of our clinic: Prof. M. Guckenberger and Prof. N. Andratschke have been instrumental in developing this method and we pass on our knowledge in a large number of international courses and congresses. We are active as international experts in guideline commissions. State-of-the-art equipment and experienced medical physicists and MTRAs contribute to treatment of optimum quality and safety.

The Department of Radiation Oncology at the USZ uses only the most modern techniques for precise radiation treatment of glomus tumors with few side effects. They are supervised by internationally renowned experts in the research and treatment of neuroendocrine tumors, including glomus tumors.

  • Radiosurgery of Glomus Jugulare Tumors: a Meta-Analysis. Guss Z et al. International Journal of Radiation Oncology, Biology, Physics 2011 Jun 81(4): 497-502.
  • Fractionated stereotactic radiotherapy of glomus jugulare tumors. Local control, toxicity, symptomatology, and quality of life Henzel et al. Radiation Oncol. 2007 Oct;183(10):557-62.

Responsible professionals

Nicolaus Andratschke, Prof. Dr. med.

Senior Physician, Vice Director of Department, Department of Radiation Oncology

Tel. +41 44 255 35 67
Specialties: Neurooncology, Thoracic oncology, Radiosurgery and MR-guided radiotherapy

Panagiotis Balermpas, Prof. Dr. med.

Senior Physician, Department of Radiation Oncology

Tel. +41 44 255 35 67
Specialties: Multimodal therapy of head and neck tumors, Organ-preserving treatment of pharyngeal and laryngeal carcinomas, Radiotherapy of skin tumors

For patients

As a patient, you cannot register directly for a consultation. Please get a referral from your primary care physician, specialist.

Contact form

For referrering physicians

Simply assign your patient online or by email.

Tel. +41 44 255 35 66
Patient registration form

Responsible Department

Related diseases